Keywords
oral cancer
podoplanin
squamous cell carcinoma
How to Cite
Abstract
BACKGROUND:
The involvement of regional lymph nodes by cancer is a major determinant of prognosis in oral squamous cell carcinoma (OSCC) and is a significant predictor of patient survival. Peri-tumoral lymphangiogenesis is being studied as an important tool in predicting neck lymph node metastasis. Podoplanin, a transmembrane glycoprotein is expressed on lymphatic vessel endothelium and considered as a marker of lymphangiogenesis. The high podoplanin expression has been associated with invasion, progression, and metastasis of oral cancer. D2-40, an anti-podoplanin monoclonal antibody, is a specific marker of lymphatic endothelial cells. The present study was designed to investigate the peritumoral lymphovascular density (PT-LVD) by evaluating D2-40 expression and its potential utility in predicting lymph node metastasis in OSCC.
METHODS: Seventy-two patients with OSCC were enrolled (36 with early and 36 with advanced-stage tumors). Differential expression of peritumoral lymphovascular density (PT-LVD) was evaluated using D2-40 expression by immunohistochemistry (IHC). Expression was categorized as low and high, derived from the mean of a number of vessels per 10 high power fields in hot-spots. Statistical methods were employed to correlate expression with age, gender, tumor site, stage, and neck lymph node involvement.
RESULTS: We observed a significant association between peritumoral lymphovascular density (PT-LVD) with clinical neck lymph node status (p=0.001) and tumor stage (p=0.033). There was no significant correlation of D2-40 expression with age, gender, tumor site, T stage, and tumor differentiation.
CONCLUSION: PT-LVD is a positive predictor of neck lymph node metastasis. It has translational potential, along with other clinical parameters for decision making in the treatment of the neck in oral cancer.
References
Asthana S, Patil RS, Labani S. Tobacco-related cancers in India: A review of incidence reported from population-based cancer registries. Indian J Med Paediatr Oncol 2016. https://doi.org/10.4103/0971-5851.190357.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. https://doi.org/10.1002/ijc.29210.
Balaram P, Sridhar H, Rajkumar T, Vaccarella S, Herrero R, Nandakumar A, et al. Oral cancer in Southern India: The influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 2002. https://doi.org/10.1002/ijc.10200.
Cerezo L, Millan I, Torre A, Aragon G, Otero J. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: A multivariate study of 492 cases. Cancer 2010;69:1224–34. https://doi.org/10.1002/cncr.2820690526.
Pantvaidya G, Rao K, D’Cruz A. Management of the neck in oral cancers. Oral Oncol 2020;100:104476. https://doi.org/10.1016/j.oraloncology.2019.104476.
Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006;47:755–62.
Pimenta Amaral TM, Da Silva Freire AR, Carvalho AL, Pinto CAL, Kowalski LP. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 2004;40:780–6. https://doi.org/10.1016/j.oraloncology.2003.10.009.
Köhler HF, Kowalski LP. A decision analysis model for elective neck dissection in patients with cT1-2 cN0 oral squamous cell carcinoma. Acta Otorhinolaryngol Ital 2019;39:374–80. https://doi.org/10.14639/0392-100X-2101.
Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometric study with clinical correlations. Cancer 2004;101:973–8. https://doi.org/10.1002/cncr.20454.
Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, et al. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 2003;25:464–74. https://doi.org/10.1002/hed.10235.
Mohammed RAA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 2007;96:1092–100. https://doi.org/10.1038/sj.bjc.6603678.
Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, et al. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 2006;139:839–46. https://doi.org/10.1016/j.surg.2005.12.008.
Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis. J Leukoc Biol 2006;80:691–6. https://doi.org/10.1189/jlb.1105653.
He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 2005;65:4739–46. https://doi.org/10.1158/0008-5472.CAN-04-4576.
Liang P, Hong JW, Ubukata H, Liu HR, Watanabe Y, Katano M, et al. Increased density and diameter of lymphatic microvessels correlate with lymph node metastasis in early stage invasive colorectal carcinoma. Virchows Arch 2006;448:570–5. https://doi.org/10.1007/s00428-006-0166-9.
Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, Zambruno G, et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 2007;204:1431–40. https://doi.org/10.1084/jem.20062642.
Hoshida T, Isaka N, Hagendoorn J, Di Tomaso E, Chen YL, Pytowski B, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications. Cancer Res 2006;66:8065–75. https://doi.org/10.1158/0008-5472.CAN-06-1392.
Van Der Auwera I, Van Den Eynden GG, Colpaert CG, Van Laere SJ, Van Dam P, Van Marck EA, et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: A histomorphometric study. Clin Cancer Res 2005;11:7637–42. https://doi.org/10.1158/1078-0432.CCR-05-1142.
Ohno F, Nakanishi H, Abe A, Seki Y, Kinoshita A, Hasegawa Y, et al. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis. J Oral Pathol Med 2007;36:281–9. https://doi.org/10.1111/j.1600-0714.2007.00529.x.
Longatto Filho A, Oliveira TG, Pinheiro C, de Carvalho MB, Curioni OA, da Cunha Mercante AM, et al. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis? World J Surg Oncol 2007;5. https://doi.org/10.1186/1477-7819-5-140.
Parmar P, Marwah N, Parshad S, Yadav T, Batra A, Sen R. Clinicopathological Significance of Tumor Lymphatic Vessel Density in Head and Neck Squamous Cell Carcinoma. Indian J Otolaryngol Head Neck Surg 2018;70:102–10. https://doi.org/10.1007/s12070-017-1216-0.
Miyahara M, Tanuma JI, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 2007;110:1287–94. https://doi.org/10.1002/cncr.22900.
Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004;25:387–95. https://doi.org/10.1016/j.it.2004.05.003.
Padera TP, Kadambi A, Di Tomaso E, Mouta Carreira C, Brown EB, Boucher Y, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics.Science(80-)2002;296:1883–6. https://doi.org/10.1126/science.1071420.
Reis-Filho JS, Schmitt FC. Lymphangiogenesis in tumors: What do we know? Microsc Res Tech 2003;60:171–80. https://doi.org/10.1002/jemt.10255.
Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005;206:170–7. https://doi.org/10.1002/path.1776.
Mehrotra R, Singh M, Kumar D, Pandey AN, Gupta RK, Sinha US. Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci 2003;57:400–4.
Shenoi R, Devrukhkar V, Chaudhuri, Sharma BK, Sapre SB, Chikhale A. Demographic and clinical profile of oral squamous cell carcinoma patients: A retrospective study. Indian J. Cancer, vol. 49, Indian J Cancer; 2012, p. 21–6. https://doi.org/10.4103/0019-509X.98910.
Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, et al. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006;107:563–9. https://doi.org/10.1002/cncr.22061.
Kreppel M, Scheer M, Drebber U, Ritter L, Zöller JE. Impact of podoplanin expression in oral squamous cell carcinoma: Clinical and histopathologic correlations. Virchows Arch 2010;456:473–82. https://doi.org/10.1007/s00428-010-0915-7.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array